Randomized Clinical Trial Comparing Oral Dydrogesterone to Micronized Vaginal Progesterone for Endometrial Preparation in Frozen-Thawed Embryo Transfer Cycle [PDF]
Clinical and Experimental Obstetrics & Gynecology, 2023 Background: The objective was to compare the use of micronized vaginal progesterone 800 mg daily and oral dydrogesterone 40 mg daily in the endometrial preparation for frozen-thawed embryo transfer (FET).
Luma Caroline Gomes Mattos de Macedo +4 more
doaj +2 more sources
Gynecological EndocrinologyPurpose This study aimed to compare the efficacies of Femoston and Dydrogesterone therapy in patients with incomplete abortions.Methods Patients with incomplete abortions were included if they preferred medication over surgical intervention.
Xueyao Huang +4 more
doaj +2 more sources
Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response [PDF]
Frontiers in Endocrinology, 2021 ObjectiveTo compare the clinical outcomes of dydrogesterone (DYG) and medroxyprogesterone (MPA) in the progestin-primed ovarian stimulation (PPOS) protocol for patients with poor ovarian response (POR).Patients and MethodsThis was a retrospective cohort ...
Junwei Zhang +6 more
doaj +2 more sources
Age-stratified analysis of euploidy rates in Progestin-Primed Ovarian Stimulation (PPOS) utilizing micronized progesterone or dydrogesterone versus GnRH analogues [PDF]
Journal of Ovarian ResearchPurposes This study aims to analyze the euploidy rates of PPOS utilizing micronized progesterone and dydrogesterone in comparison to conventional controlled ovarian stimulation (COS) protocols in pre-implantation genetic testing for aneuploidy (PGT-A ...
Rang Liu +8 more
doaj +2 more sources
Real-world evaluation of safety and effectiveness of dydrogesterone in the management of threatened abortion [PDF]
, 2022 Background: Threatened abortion is a relatively common complication during pregnancy. Inadequate production of endogenous progesterone is implicated as a risk factor for miscarriages.
Chinda, Monika +7 more
core +4 more sources
PLoS ONE, 2020 The aim of this systematic review and meta-analysis was to conduct a comprehensive assessment of the evidence on the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support. Embase and MEDLINE were
Georg Griesinger +6 more
doaj +2 more sources
No improvement in pregnancy and perinatal outcomes with combined luteal support in modified natural cycle frozen embryo transfer [PDF]
Frontiers in EndocrinologyObjectiveWe investigated whether the addition of a luteal phase support drug benefits pregnancy and perinatal outcomes in modified natural-cycle frozen-thawed embryo transfer (mNC-FET) for women up to the age of 35 years.MethodsWe analyzed the clinical ...
Wen Zhang +7 more
doaj +2 more sources
Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study [PDF]
International Journal of Reproductive BioMedicineBackground: Currently, frozen embryo transfers (FET) account for 41% of all embryo transfer cycles. Vaginal progesterone preparations have become the leading choice for luteal phase support due to their convenient application; however, using only ...
Sahereh Arabian +4 more
doaj +2 more sources
Gynecological EndocrinologyObjective To compare dydrogesterone versus levonorgestrel-releasing intrauterine system (LNG-IUS) for abnormal uterine bleeding (AUB) management with long-term follow-up and etiology-stratified analysis.Methods This single-center retrospective cohort ...
Xiaoli Wei, Li Huang, Xiangzun Li
doaj +2 more sources
Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance. [PDF]
Hum Reprod OpenChouchana L +7 more
europepmc +3 more sources